Antibody Response to SARS-CoV-2 Vaccination in Patients with End-Stage Kidney Disease on Hemodialysis

Antibody Response to SARS-CoV-2 Vaccination in Patients with End-Stage Kidney Disease on Hemodialysis

Patients with end-stage kidney disease on hemodialysis (ESKD-HD) have a high risk of contracting severe COVID-19. Vaccination can help reduce disease severity, but the immune dysregulation observed in these patients may result in an inadequate antibody response. Therefore, we aimed to evaluate the i...

Full description

Bibliographic Details
Main Authors: Rizky Andhika, Muhammad Iqbal Anand, Marita Restie Tiara, Josephine Debora, Hofiya Djauhari, Evan Susandi, Adnes Mareta, Asep Riswoko, Nopi Susilawati, Agnes Rengga Indrati, Bachti Alisjahbana, Rudi Supriyadi
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Vaccines
Subjects:
COVID-19
chronic kidney disease
antibody level
vaccination
Online Access:https://www.mdpi.com/2076-393X/11/12/1802

Internet

https://www.mdpi.com/2076-393X/11/12/1802

Similar Items